Research database

SVF Research Library

Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 75 matching records.

Search the database

Evidence

Sort

75 results — page 1 of 4

Level DNarrative ReviewEurope PMC
Modelling neurocardiac physiology and diseases using human pluripotent stem cells: current progress and future prospects
Narrative Review on Cardiovascular Disease, published in J Physiol (2025) — summary generated from the PubMed abstract.
2025
J Physiol
2 citations
Level DAnimal StudyPubMed
Conditioned medium from human adipose-derived mesenchymal stem cells attenuates cardiac injury induced by Movento in male rats: role of oxidative stress and inflammation.
Animal Study on Cardiovascular Disease, published in BMC Pharmacol Toxicol (2025) — summary generated from the PubMed abstract.
2025
BMC Pharmacol Toxicol
3 citations
Level DAnimal StudyPubMed
Enhanced human adipose-derived stem cells with VEGFA and bFGF mRNA promote stable vascular regeneration and improve cardiac function following myocardial infarction.
Animal Study on Cardiovascular Disease, published in Clin Transl Med (2025) — summary generated from the PubMed abstract.
2025
Clin Transl Med
10 citations
Level DAnimal StudyPubMed
3D bioprinting of human iPSC-derived cardiac constructs with microvascular network support for improved graft survival in vivo .
Animal Study on Cardiovascular Disease, published in Biofabrication (2025) — summary generated from the PubMed abstract.
2025
Biofabrication
Level DLaboratory StudyEurope PMC
Contractile and Genetic Characterization of Cardiac Constructs Engineered from Human Induced Pluripotent Stem Cells: Modeling of Tuberous Sclerosis Complex and the Effects of Rapamycin
Laboratory Study on Cardiovascular Disease, published in Bioengineering (Basel) (2024) — summary generated from the PubMed abstract.
2024
Bioengineering (Basel)
1 citations
Level DLaboratory StudyPubMed
Cardiac fat adipocytes: An optimized protocol for isolation of ready-to-use mature adipocytes from human pericardial adipose tissue.
Laboratory Study on Cardiovascular Disease, Chronic Inflammation, published in J Mol Cell Cardiol (2024) — summary generated from the PubMed abstract.
2024
J Mol Cell Cardiol
1 citations
Level CProspective StudyPubMed
Obesity blunts amelioration of cardiac hypertrophy and fibrosis by human mesenchymal stem/stromal cell-derived extracellular vesicles.
Prospective Study on Cardiovascular Disease, published in Am J Physiol Heart Circ Physiol (2023) — summary generated from the PubMed abstract.
2023
Am J Physiol Heart Circ Physiol
Level BClinical TrialEurope PMC
Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications-Are We on the Road to Success?
Clinical Trial on Cardiovascular Disease, published in Cells (2023) — summary generated from the PubMed abstract.
2023
Cells
24 citations
Level DAnimal StudyEurope PMC
Nanowired human cardiac organoid transplantation enables highly efficient and effective recovery of infarcted hearts
Animal Study on Cardiovascular Disease, published in Sci Adv (2023) — summary generated from the PubMed abstract.
2023
Sci Adv
46 citations
Level DAnimal StudyPubMed
Human adipose-derived stem cells preconditioned with a novel herbal formulation Jing Shi attenuate doxorubicin-induced cardiac damage.
Animal Study on Cardiovascular Disease, published in Aging (Albany NY) (2023) — summary generated from the PubMed abstract.
2023
Aging (Albany NY)
8 citations
Level DNarrative ReviewEurope PMC
A review of protocols for engineering human cardiac organoids
Narrative Review on Cardiovascular Disease, published in Heliyon (2023) — summary generated from the PubMed abstract.
2023
Heliyon
2 citations
Level DAnimal StudyEurope PMC
Human Decidual Mesenchymal Stem Cells Obtained From Early Pregnancy Improve Cardiac Revascularization Postinfarction by Activating Ornithine Metabolism
Animal Study on Cardiovascular Disease, published in Front Cardiovasc Med (2022) — summary generated from the PubMed abstract.
2022
Front Cardiovasc Med
10 citations
Level DNarrative ReviewEurope PMC
A Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development
Narrative Review on Cardiovascular Disease, published in Curr Cardiol Rep (2022) — summary generated from the PubMed abstract.
2022
Curr Cardiol Rep
21 citations
Level CProspective StudyEurope PMC
Human Cardiac Organoids to Model COVID-19 Cytokine Storm Induced Cardiac Injuries
Prospective Study with a reported sample of 19 on Cardiovascular Disease, Immune Modulation, published in (2022) — summary generated from the PubMed abstract.
2022
30 citations
n = 19
Level DLaboratory StudyPubMed
Stem cell-derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy-In a model of human-induced pluripotent stem cell-derived cardiomyocytes.
Laboratory Study on Cardiovascular Disease, published in Front Pharmacol (2022) — summary generated from the PubMed abstract.
2022
Front Pharmacol
22 citations
Level DAnimal StudyPubMed
Bioactive decellularized cardiac extracellular matrix-based hydrogel as a sustained-release platform for human adipose tissue-derived stromal cell-secreted factors.
Animal Study on Cardiovascular Disease, published in Biomed Mater (2021) — summary generated from the PubMed abstract.
2021
Biomed Mater
Level BClinical TrialPubMed
Challenges and Limitations of Strategies to Promote Therapeutic Potential of Human Mesenchymal Stem Cells for Cell-Based Cardiac Repair.
Clinical Trial on Cardiovascular Disease, published in Korean Circ J (2021) — summary generated from the PubMed abstract.
2021
Korean Circ J
23 citations
Level CProspective StudyPubMed
Cardiac glycosides cause cytotoxicity in human macrophages and ameliorate white adipose tissue homeostasis.
Prospective Study on Cardiovascular Disease, published in Br J Pharmacol (2021) — summary generated from the PubMed abstract.
2021
Br J Pharmacol
16 citations
Level DLaboratory StudyEurope PMC
Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells
Laboratory Study on Cardiovascular Disease, published in Nat Protoc (2021) — summary generated from the PubMed abstract.
2021
Nat Protoc
100 citations
Level DLaboratory StudyEurope PMC
Targeting HIF-α for robust prevascularization of human cardiac organoids
Laboratory Study on Cardiovascular Disease, published in J Tissue Eng Regen Med (2021) — summary generated from the PubMed abstract.
2021
J Tissue Eng Regen Med
17 citations
Level CProspective StudyPubMed
Neuropeptide Y promotes adipogenesis of human cardiac mesenchymal stromal cells in arrhythmogenic cardiomyopathy.
Prospective Study on Cardiovascular Disease, published in Int J Cardiol (2021) — summary generated from the PubMed abstract.
2021
Int J Cardiol
Level DNarrative ReviewEurope PMC
Heart Organoids and Engineered Heart Tissues: Novel Tools for Modeling Human Cardiac Biology and Disease
Narrative Review on Cardiovascular Disease, published in Biomolecules (2021) — summary generated from the PubMed abstract.
2021
Biomolecules
38 citations
Level DLaboratory StudyEurope PMC
Conversion of human cardiac progenitor cells into cardiac pacemaker-like cells
Laboratory Study on Cardiovascular Disease, published in J Mol Cell Cardiol (2020) — summary generated from the PubMed abstract.
2020
J Mol Cell Cardiol
19 citations
Level CProspective StudyPubMed
Differential expression of microRNA and arachidonic acid metabolism in aspirin-treated human cardiac and peri-cardiac fat-derived mesenchymal stem cells.
Prospective Study on Cardiovascular Disease, Chronic Inflammation, published in Vascul Pharmacol (2020) — summary generated from the PubMed abstract.
2020
Vascul Pharmacol

In-depth reviewed studies (full Thai translation)

Evidence system

SVF Research Library

Modelling neurocardiac physiology and diseases using human pluripotent stem cells: current progress and future prospects

Conditioned medium from human adipose-derived mesenchymal stem cells attenuates cardiac injury induced by Movento in male rats: role of oxidative stress and inflammation.

Enhanced human adipose-derived stem cells with VEGFA and bFGF mRNA promote stable vascular regeneration and improve cardiac function following myocardial infarction.

3D bioprinting of human iPSC-derived cardiac constructs with microvascular network support for improved graft survival in vivo .

Contractile and Genetic Characterization of Cardiac Constructs Engineered from Human Induced Pluripotent Stem Cells: Modeling of Tuberous Sclerosis Complex and the Effects of Rapamycin

Cardiac fat adipocytes: An optimized protocol for isolation of ready-to-use mature adipocytes from human pericardial adipose tissue.

Obesity blunts amelioration of cardiac hypertrophy and fibrosis by human mesenchymal stem/stromal cell-derived extracellular vesicles.

Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications-Are We on the Road to Success?

Nanowired human cardiac organoid transplantation enables highly efficient and effective recovery of infarcted hearts

Human adipose-derived stem cells preconditioned with a novel herbal formulation Jing Shi attenuate doxorubicin-induced cardiac damage.

A review of protocols for engineering human cardiac organoids

Human Decidual Mesenchymal Stem Cells Obtained From Early Pregnancy Improve Cardiac Revascularization Postinfarction by Activating Ornithine Metabolism

A Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development

Human Cardiac Organoids to Model COVID-19 Cytokine Storm Induced Cardiac Injuries

Stem cell-derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy-In a model of human-induced pluripotent stem cell-derived cardiomyocytes.

Bioactive decellularized cardiac extracellular matrix-based hydrogel as a sustained-release platform for human adipose tissue-derived stromal cell-secreted factors.

Challenges and Limitations of Strategies to Promote Therapeutic Potential of Human Mesenchymal Stem Cells for Cell-Based Cardiac Repair.

Cardiac glycosides cause cytotoxicity in human macrophages and ameliorate white adipose tissue homeostasis.

Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells

Targeting HIF-α for robust prevascularization of human cardiac organoids

Neuropeptide Y promotes adipogenesis of human cardiac mesenchymal stromal cells in arrhythmogenic cardiomyopathy.

Heart Organoids and Engineered Heart Tissues: Novel Tools for Modeling Human Cardiac Biology and Disease

Conversion of human cardiac progenitor cells into cardiac pacemaker-like cells

Differential expression of microRNA and arachidonic acid metabolism in aspirin-treated human cardiac and peri-cardiac fat-derived mesenchymal stem cells.

In-depth reviewed studies (full Thai translation)

Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial

Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials

Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis